A novel compound for treatment of T cell leukemia |
Huntsman Cancer Institute / Nikolaus Trede |
Innovation Grants |
2010 |
Utah |
Elucidating the Initiation Mechanism of the Fanconi Anemia Pathway of DNA Damage Repair |
Yale School of Medicine / Yong Xiong |
Innovation Grants |
2010 |
Connecticut |
In-UTR Mutations in Neuroblastoma: Functional Consequences and Therapeutic Implications |
Children’s Hospital of Philadelphia / Andrei Thomas-Tikhonenko |
Innovation Grants |
2010 |
Pennsylvania |
Identification of New Therapeutic Targets in Pediatric Acute Lymphoblastic Leukemia Through Mosaic Trisomy and Aneuploidy-Based Synthetic Lethality Screens |
Dana-Farber Cancer Institute / David Pellman |
Innovation Grants |
2010 |
Massachusetts |
Pathogenesis of T-cell Acute Lymphoblastic Leukemia from Myeloproliferative Disorder |
Duke University / Motonari Kondo |
Innovation Grants |
2010 |
North Carolina |
Targeting wnt in synovial sarcoma models.
|
Vanderbilt University Medical Center / Josiane Eid |
Innovation Grants |
2009 |
Tennessee |
Pharmacogenomics of childhood AML susceptibility and treatment response.
|
Children’s Hospital of Philadelphia / Richard Aplenc |
Innovation Grants |
2009 |
Pennsylvania |
Targeted regulation of acetylation as novel therapy for Ewing sarcoma.
|
Georgetown University / Jeffrey Toretsky |
Innovation Grants |
2009 |
District of Columbia |
Epigenetic manipulation of leukemia.
|
Cincinnati Children's Hospital Medical Center / H. Leighton Grimes |
Innovation Grants |
2009 |
Ohio |
Adaptation of acute lymphoblastic leukemia (ALL) to the post-transplant allogeneic environment.
|
University of Rochester / Craig Mullen |
Innovation Grants |
2009 |
New York |